Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Behavioral Neurology
Is a history of coronary artery disease and afib a contraindication to using donepezil?
How do you counsel patients about any potential risk?
Related Questions
What is your approach to patients who develop ARIA-E or ARIA-H during treatment with anti-amyloid therapies?
How does APOE4 status affect your clinical decision-making in patients who may be eligible for anti-amyloid therapies for early Alzheimer's disease?
What are the best practices for centers interested in providing anti-amyloid therapies for early Alzheimer's to ensure treatment delivery success?
Is the p-tau217 plasma test used as a surrogate for amyloid PET scan or CSF testing when considering starting Leqembi in patients with Alzheimer's disease?
Do you use amyloid lowering therapy in patients on chronic anticoagulation?
What is the minimum level of cognitive symptoms that would prompt you to pursue biomarker testing required for anti-amyloid therapies for Alzheimer's?
How do you counsel eligible patients on how to decide between lecanemab vs donanemab?
How do you approach an isolated increased protein levels in the CSF in patients with cognitive decline?
What would prompt discontinuing treatment versus switching or sequencing treatment in patients treated with an anti-amyloid therapy for Alzheimer's?
What outpatient therapies do you recommend for continuous or severe pain from migraine that is refractory to acute therapies?